Accordingly, EGR1, EGR2, and EGR3 were differentially expressed genes (DEGs) in several cancers, such as bladder urothelial carcinoma (BLCA), BRCA, and lung adenocarcinoma (LUAD). This evidence concerns the gene EGR3 and bladder transitional cell carcinoma.